At Cotton Craft (Pvt) Ltd, every wound care solution begins with one goal — faster healing through scientifically crafted materials. In modern wound management, preventing infection while maintaining an optimal healing environment represents a critical clinical challenge. Bacterial colonization can transform minor injuries into serious complications, delay healing in burn patients, and compromise the success of skin grafting procedures. Our Polygrass Dressing addresses these challenges through the integration of proven antimicrobial agents with advanced dressing technology.
At Cotton Craft (Pvt) Ltd, every wound care solution begins with one goal — faster healing through scientifically crafted materials. In modern wound management, preventing infection while maintaining an optimal healing environment represents a critical clinical challenge. Bacterial colonization can transform minor injuries into serious complications, delay healing in burn patients, and compromise the success of skin grafting procedures. Our Polygrass Dressing addresses these challenges through the integration of proven antimicrobial agents with advanced dressing technology.
The development of antimicrobial wound dressings requires expertise beyond textile manufacturing — it demands pharmaceutical formulation science, microbiological validation, and precision drug delivery systems. Since our establishment in Lahore, Pakistan, Cotton Craft has invested in the research capabilities and manufacturing infrastructure necessary to produce pharmaceutical-grade wound care products. Our commitment to “Healing with Excellence” extends into this sophisticated category where material engineering meets antimicrobial therapy.
Our Polygrass Dressing — 10cm×10cm sterile format combining Bacitracin Zinc and Polymyxin B Sulphate in paraffin-impregnated leno gauze — represents the convergence of antibiotic science, textile engineering, and pharmaceutical manufacturing precision.
Research & Development: Engineering Antimicrobial Protection
The development of Polygrass Dressing began with fundamental questions in our research laboratories: How do we deliver effective antimicrobial concentrations to wound surfaces while maintaining gauze conformability? What combination of antibiotics provides optimal broad-spectrum coverage without promoting resistance? How should paraffin impregnation be optimized to prevent tissue adherence while supporting drug delivery?
Our medical advisors and pharmaceutical scientists studied international literature on topical antimicrobial therapy, examining clinical evidence for various antibiotic combinations in wound care. The research focused on understanding the synergistic action between Bacitracin Zinc and Polymyxin B Sulphate — two antibiotics with complementary mechanisms and bacterial spectrum coverage.
Bacitracin Zinc demonstrates potent activity against gram-positive bacteria including Staphylococcus aureus and Streptococcus species — common wound pathogens responsible for wound infections. Polymyxin B Sulphate provides essential gram-negative coverage against organisms like Pseudomonas aeruginosa and Escherichia coli. Together, these agents create broad-spectrum antimicrobial protection addressing the diverse bacterial populations that colonize wounds.
Our R&D team consulted with microbiologists to understand minimum inhibitory concentrations required for clinical effectiveness. Formulation studies determined optimal antibiotic loading levels that would deliver therapeutic concentrations to wound tissues without systemic absorption concerns. Stability testing evaluated how the antibiotics perform when incorporated into paraffin-impregnated gauze matrices under various storage conditions.
The substrate selection required careful consideration. Leno gauze — with its distinctive open-weave structure created by twisted warp yarns — provides several advantages for antimicrobial dressings. The open mesh allows exudate drainage while maintaining contact between the antibiotic-impregnated surface and wound bed. We studied British Pharmacopoeia (BP) specifications for leno gauze to ensure our substrate met pharmaceutical standards for uniformity and quality.
Paraffin impregnation chemistry became a critical research focus. The paraffin serves multiple functions: it prevents gauze adherence to healing tissue, creates a moist wound environment that supports epithelialization, and acts as a carrier matrix for the antimicrobial agents. Our team tested various paraffin grades and impregnation levels to optimize the balance between non-adherence and drug delivery characteristics.
Extensive microbiological testing validated the dressing’s antimicrobial efficacy. Laboratory studies employed standardized challenge testing with common wound pathogens to confirm that the antibiotic-impregnated dressing achieved specified bacterial reduction levels. Time-kill studies demonstrated sustained antimicrobial activity throughout anticipated wear periods.
Clinical Field Evaluation: Validation Across Wound Types
Cotton Craft’s medical advisors conducted comprehensive field testing across burn units, surgical departments, plastic surgery centers, and wound care clinics throughout Pakistan. Our objective was validating Polygrass Dressing performance across the diverse applications for which antimicrobial protection proves critical.
Burn specialists evaluated the dressing on patients with partial-thickness burns and scalds — wounds particularly vulnerable to infection due to compromised skin barrier function. Surgeons assessed performance on donor and recipient graft sites where infection prevention directly impacts grafting success. Emergency physicians tested the product on lacerations, abrasions, and traumatic skin loss wounds. Wound care specialists applied it to chronic leg ulcers where bacterial biofilms complicate healing.
The clinical feedback revealed important performance characteristics. Burn unit nurses reported that the paraffin impregnation prevented painful adherence to burn wounds, allowing dressing changes without traumatizing newly formed epithelium. The antimicrobial action reduced infection rates in vulnerable burn patients, supporting faster healing progression.
One plastic surgeon at a major teaching hospital in Lahore noted: “Protecting skin graft sites from infection is absolutely critical to surgical success. This antimicrobial dressing provides the bacterial protection we need while the non-adherent properties prevent disruption of delicate graft integration.”
Emergency department physicians appreciated the broad-spectrum coverage for contaminated traumatic wounds where bacterial load presents immediate infection risk. The combination of Bacitracin and Polymyxin B addressed both gram-positive and gram-negative organisms commonly introduced through environmental contamination.
Wound care specialists managing chronic leg ulcers observed improved healing rates when bacterial colonization was controlled with Polygrass Dressing. The sustained antimicrobial release maintained a clean wound bed conducive to granulation tissue formation.
Clinical evaluation also identified important patient safety considerations. Healthcare providers recognized the importance of monitoring for hypersensitivity reactions, particularly in patients with known antibiotic allergies. The contraindication for fungal or viral lesions was reinforced through clinical experience, as antimicrobial dressings should only be applied to appropriate bacterial-susceptible wounds.
Field testing validated practical handling characteristics. The 10cm×10cm size proved versatile for diverse wound dimensions, easily cut to fit smaller areas or combined for larger surfaces. The leno gauze structure remained conformable despite antibiotic and paraffin incorporation, allowing application to irregular wound contours.
In-House Manufacturing Excellence: Pharmaceutical-Grade Production
At our state-of-the-art facility in Sundar Industrial Estate, Lahore, Polygrass Dressing production occurs in dedicated pharmaceutical manufacturing areas designed for antibiotic-containing medical devices. This product category requires environmental controls, quality systems, and documentation practices that exceed conventional textile manufacturing standards.
We source pharmaceutical-grade Bacitracin Zinc and Polymyxin B Sulphate from qualified suppliers with comprehensive certificates of analysis confirming potency, purity, and compliance with pharmacopoeial standards. These active pharmaceutical ingredients undergo rigorous incoming inspection including identity testing, potency assays, and microbial quality assessment.
Medical-grade paraffin meeting specific melting point, viscosity, and purity specifications is procured from certified suppliers. The paraffin must be free from contaminants that could provoke tissue reactions or interfere with antibiotic stability.
Leno gauze conforming to BP specifications is manufactured or procured with verified quality documentation. The distinctive leno weave — created by twisting adjacent warp threads around weft yarns — must demonstrate uniform mesh structure, appropriate thread count, and consistent dimensional characteristics.
The impregnation process employs controlled pharmaceutical manufacturing equipment where paraffin is heated to precise temperatures and combined with calibrated quantities of Bacitracin Zinc and Polymyxin B Sulphate. Mixing systems ensure homogeneous antibiotic dispersion throughout the paraffin matrix. The leno gauze passes through the heated antibiotic-paraffin mixture under controlled conditions that ensure consistent impregnation throughout the fabric structure.
Cooling and solidification occur under monitored conditions that prevent antibiotic degradation while allowing the paraffin to set uniformly. Automated cutting systems prepare the gauze to precise 10cm×10cm dimensions with clean edges that won’t fray during handling.
Sterilization employs validated methods appropriate for antibiotic-containing products. Our sterilization protocols achieve complete microbial elimination while preserving antibiotic potency. Extensive validation studies confirm that our sterilization process doesn’t degrade the active pharmaceutical ingredients or alter the paraffin matrix properties.
Individual packaging occurs in controlled cleanroom environments using medical-grade materials that protect sterility and maintain product stability. Each sterile dressing is sealed in packaging designed to prevent light exposure and maintain storage integrity. Packaging includes clear labeling with antibiotic identification, precautions, contraindications, and storage requirements.
Our facility operates under Good Manufacturing Practice (GMP) protocols appropriate for pharmaceutical products. Environmental monitoring, equipment calibration, personnel training, and comprehensive batch documentation ensure complete quality traceability and regulatory compliance.
Temperature-controlled storage areas maintain products below 25°C as specified, with additional protection from direct sunlight that could degrade antibiotic potency or alter paraffin characteristics.
Laboratory Quality Control: Pharmaceutical Validation
Every batch of Polygrass Dressing undergoes rigorous examination by our Quality Control Department employing both pharmaceutical and medical device testing methodologies. Our protocols validate antibiotic potency, antimicrobial efficacy, and product safety.
Antibiotic potency assays employ microbiological methods to quantify Bacitracin Zinc and Polymyxin B Sulphate concentrations in the finished dressing. High-performance liquid chromatography (HPLC) or standardized bioassays confirm that antibiotic levels meet label claims within acceptable ranges. Only batches demonstrating specified potency proceed to release.
Antimicrobial efficacy testing validates the dressing’s ability to inhibit bacterial growth. Standardized challenge tests expose dressing samples to known concentrations of relevant bacterial species including Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. Zone of inhibition measurements or time-kill assays confirm effective antimicrobial action.
Sterility testing employs pharmacopoeial methods confirming complete absence of viable microorganisms. This testing is critical as any contamination could compromise patient safety and product effectiveness.
Paraffin impregnation uniformity testing ensures consistent distribution throughout the gauze structure. Samples from different dressing sections undergo paraffin content analysis to verify uniform impregnation that will provide consistent non-adherence and drug delivery characteristics.
Gauze substrate quality testing confirms the leno weave meets BP specifications including thread count, yarn fineness, weave uniformity, and dimensional accuracy. Physical testing verifies appropriate tensile strength and conformability.
Antibiotic stability testing monitors potency retention under accelerated aging conditions simulating extended storage. These studies confirm shelf life determinations and validate storage temperature requirements.
Packaging integrity testing ensures hermetic sealing that maintains sterility and protects against light and moisture that could degrade antibiotics. Package strength testing confirms the packaging protects product integrity throughout distribution.
Chemical purity testing verifies the paraffin and antibiotics contain no harmful contaminants or degradation products that could provoke adverse reactions.
No batch of Polygrass Dressing receives Cotton Craft certification without documented evidence that all pharmaceutical and device quality parameters meet specifications.
Verification & Market Validation: Trusted in Critical Applications
Following successful validation, Cotton Craft introduced Polygrass Dressing to burn units, surgical departments, wound care centers, and healthcare distributors throughout Pakistan and international markets. The response from specialists managing infection-vulnerable wounds has validated our pharmaceutical manufacturing capabilities and product design.
Burn care specialists consistently report satisfaction with infection prevention in thermal injury patients. The combination of broad-spectrum antimicrobial coverage and non-adherent paraffin impregnation supports the delicate balance required in burn wound management — controlling infection while promoting epithelial regeneration.
Plastic surgeons value the product’s performance on skin graft sites where even minor bacterial colonization can cause graft failure. The sustained antimicrobial release throughout the critical integration period supports improved graft survival rates.
Emergency departments appreciate having a readily available antimicrobial dressing for contaminated traumatic wounds requiring immediate infection prevention. The broad-spectrum coverage addresses the diverse bacterial populations encountered in environmental injuries.
Wound care clinics managing chronic leg ulcers report improved healing progression when bacterial burden is controlled with Polygrass Dressing. The combination therapy addresses the polymicrobial nature of chronic wound infections more effectively than single-agent products.
Healthcare distributors benefit from our comprehensive pharmaceutical documentation including stability data, microbiological validation, and manufacturing compliance records that support regulatory submissions and hospital formulary approvals.
Clinical feedback has reinforced the importance of appropriate patient selection. Healthcare providers report excellent outcomes when the dressing is used for bacterial-susceptible wounds with proper monitoring for hypersensitivity. Adherence to contraindications — avoiding use on fungal or viral lesions — ensures optimal clinical results.
Cotton Craft: Advancing Antimicrobial Wound Care
Polygrass Dressing represents Cotton Craft’s evolution into pharmaceutical-grade wound care products that integrate drug therapy with advanced dressing technology. The successful development and manufacturing of antibiotic-containing dressings demonstrates our commitment to expanding capabilities beyond conventional textiles into sophisticated medical devices.
Every Polygrass Dressing reflects our understanding that effective antimicrobial wound care requires pharmaceutical expertise, microbiological validation, and manufacturing precision that ensures consistent drug delivery. From antibiotic selection based on clinical evidence through formulation optimization and pharmaceutical quality control, each development step serves the goal of providing reliable infection prevention.
Whether protecting burn patients from life-threatening infections, supporting successful skin graft integration, managing contaminated traumatic wounds, or controlling bacterial colonization in chronic ulcers, healthcare professionals can trust that Cotton Craft Polygrass Dressing delivers verified antimicrobial efficacy, pharmaceutical-grade quality, and proven clinical performance.
For burn units, surgical departments, wound care centers, and distributors seeking antimicrobial dressing solutions backed by pharmaceutical manufacturing excellence, Cotton Craft offers specialized products, comprehensive technical support, and regulatory documentation that facilitates formulary approval and clinical adoption.
Cotton Craft continues to advance wound care technology — where every product is backed by research and real-world proof.
Important Safety Information
Precautions: Prolonged use may result in overgrowth of non-susceptible organisms, including fungi. Monitor patients for signs of secondary infection. If any signs or symptoms of hypersensitivity reaction develop (rash, itching, swelling), immediately discontinue use and consult a physician.
Contraindications: This product is contraindicated in individuals who have shown hypersensitivity to Bacitracin, Polymyxin B, or any components. Also contraindicated for fungal or viral lesions of the skin. Use only on bacterial-susceptible wounds as directed by healthcare professionals.
Storage: Store at temperatures not exceeding 25°C. Protect from direct sunlight which may degrade antibiotic potency. Keep in original packaging until use to maintain sterility and product stability.
The development of antimicrobial wound dressings requires expertise beyond textile manufacturing — it demands pharmaceutical formulation science, microbiological validation, and precision drug delivery systems. Since our establishment in Lahore, Pakistan, Cotton Craft has invested in the research capabilities and manufacturing infrastructure necessary to produce pharmaceutical-grade wound care products. Our commitment to “Healing with Excellence” extends into this sophisticated category where material engineering meets antimicrobial therapy.
Our Polygrass Dressing — 10cm×10cm sterile format combining Bacitracin Zinc and Polymyxin B Sulphate in paraffin-impregnated leno gauze — represents the convergence of antibiotic science, textile engineering, and pharmaceutical manufacturing precision.
Research & Development: Engineering Antimicrobial Protection
The development of Polygrass Dressing began with fundamental questions in our research laboratories: How do we deliver effective antimicrobial concentrations to wound surfaces while maintaining gauze conformability? What combination of antibiotics provides optimal broad-spectrum coverage without promoting resistance? How should paraffin impregnation be optimized to prevent tissue adherence while supporting drug delivery?
Our medical advisors and pharmaceutical scientists studied international literature on topical antimicrobial therapy, examining clinical evidence for various antibiotic combinations in wound care. The research focused on understanding the synergistic action between Bacitracin Zinc and Polymyxin B Sulphate — two antibiotics with complementary mechanisms and bacterial spectrum coverage.
Bacitracin Zinc demonstrates potent activity against gram-positive bacteria including Staphylococcus aureus and Streptococcus species — common wound pathogens responsible for wound infections. Polymyxin B Sulphate provides essential gram-negative coverage against organisms like Pseudomonas aeruginosa and Escherichia coli. Together, these agents create broad-spectrum antimicrobial protection addressing the diverse bacterial populations that colonize wounds.
Our R&D team consulted with microbiologists to understand minimum inhibitory concentrations required for clinical effectiveness. Formulation studies determined optimal antibiotic loading levels that would deliver therapeutic concentrations to wound tissues without systemic absorption concerns. Stability testing evaluated how the antibiotics perform when incorporated into paraffin-impregnated gauze matrices under various storage conditions.
The substrate selection required careful consideration. Leno gauze — with its distinctive open-weave structure created by twisted warp yarns — provides several advantages for antimicrobial dressings. The open mesh allows exudate drainage while maintaining contact between the antibiotic-impregnated surface and wound bed. We studied British Pharmacopoeia (BP) specifications for leno gauze to ensure our substrate met pharmaceutical standards for uniformity and quality.
Paraffin impregnation chemistry became a critical research focus. The paraffin serves multiple functions: it prevents gauze adherence to healing tissue, creates a moist wound environment that supports epithelialization, and acts as a carrier matrix for the antimicrobial agents. Our team tested various paraffin grades and impregnation levels to optimize the balance between non-adherence and drug delivery characteristics.
Extensive microbiological testing validated the dressing’s antimicrobial efficacy. Laboratory studies employed standardized challenge testing with common wound pathogens to confirm that the antibiotic-impregnated dressing achieved specified bacterial reduction levels. Time-kill studies demonstrated sustained antimicrobial activity throughout anticipated wear periods.
Clinical Field Evaluation: Validation Across Wound Types
Cotton Craft’s medical advisors conducted comprehensive field testing across burn units, surgical departments, plastic surgery centers, and wound care clinics throughout Pakistan. Our objective was validating Polygrass Dressing performance across the diverse applications for which antimicrobial protection proves critical.
Burn specialists evaluated the dressing on patients with partial-thickness burns and scalds — wounds particularly vulnerable to infection due to compromised skin barrier function. Surgeons assessed performance on donor and recipient graft sites where infection prevention directly impacts grafting success. Emergency physicians tested the product on lacerations, abrasions, and traumatic skin loss wounds. Wound care specialists applied it to chronic leg ulcers where bacterial biofilms complicate healing.
The clinical feedback revealed important performance characteristics. Burn unit nurses reported that the paraffin impregnation prevented painful adherence to burn wounds, allowing dressing changes without traumatizing newly formed epithelium. The antimicrobial action reduced infection rates in vulnerable burn patients, supporting faster healing progression.
One plastic surgeon at a major teaching hospital in Lahore noted: “Protecting skin graft sites from infection is absolutely critical to surgical success. This antimicrobial dressing provides the bacterial protection we need while the non-adherent properties prevent disruption of delicate graft integration.”
Emergency department physicians appreciated the broad-spectrum coverage for contaminated traumatic wounds where bacterial load presents immediate infection risk. The combination of Bacitracin and Polymyxin B addressed both gram-positive and gram-negative organisms commonly introduced through environmental contamination.
Wound care specialists managing chronic leg ulcers observed improved healing rates when bacterial colonization was controlled with Polygrass Dressing. The sustained antimicrobial release maintained a clean wound bed conducive to granulation tissue formation.
Clinical evaluation also identified important patient safety considerations. Healthcare providers recognized the importance of monitoring for hypersensitivity reactions, particularly in patients with known antibiotic allergies. The contraindication for fungal or viral lesions was reinforced through clinical experience, as antimicrobial dressings should only be applied to appropriate bacterial-susceptible wounds.
Field testing validated practical handling characteristics. The 10cm×10cm size proved versatile for diverse wound dimensions, easily cut to fit smaller areas or combined for larger surfaces. The leno gauze structure remained conformable despite antibiotic and paraffin incorporation, allowing application to irregular wound contours.
In-House Manufacturing Excellence: Pharmaceutical-Grade Production
At our state-of-the-art facility in Sundar Industrial Estate, Lahore, Polygrass Dressing production occurs in dedicated pharmaceutical manufacturing areas designed for antibiotic-containing medical devices. This product category requires environmental controls, quality systems, and documentation practices that exceed conventional textile manufacturing standards.
We source pharmaceutical-grade Bacitracin Zinc and Polymyxin B Sulphate from qualified suppliers with comprehensive certificates of analysis confirming potency, purity, and compliance with pharmacopoeial standards. These active pharmaceutical ingredients undergo rigorous incoming inspection including identity testing, potency assays, and microbial quality assessment.
Medical-grade paraffin meeting specific melting point, viscosity, and purity specifications is procured from certified suppliers. The paraffin must be free from contaminants that could provoke tissue reactions or interfere with antibiotic stability.
Leno gauze conforming to BP specifications is manufactured or procured with verified quality documentation. The distinctive leno weave — created by twisting adjacent warp threads around weft yarns — must demonstrate uniform mesh structure, appropriate thread count, and consistent dimensional characteristics.
The impregnation process employs controlled pharmaceutical manufacturing equipment where paraffin is heated to precise temperatures and combined with calibrated quantities of Bacitracin Zinc and Polymyxin B Sulphate. Mixing systems ensure homogeneous antibiotic dispersion throughout the paraffin matrix. The leno gauze passes through the heated antibiotic-paraffin mixture under controlled conditions that ensure consistent impregnation throughout the fabric structure.
Cooling and solidification occur under monitored conditions that prevent antibiotic degradation while allowing the paraffin to set uniformly. Automated cutting systems prepare the gauze to precise 10cm×10cm dimensions with clean edges that won’t fray during handling.
Sterilization employs validated methods appropriate for antibiotic-containing products. Our sterilization protocols achieve complete microbial elimination while preserving antibiotic potency. Extensive validation studies confirm that our sterilization process doesn’t degrade the active pharmaceutical ingredients or alter the paraffin matrix properties.
Individual packaging occurs in controlled cleanroom environments using medical-grade materials that protect sterility and maintain product stability. Each sterile dressing is sealed in packaging designed to prevent light exposure and maintain storage integrity. Packaging includes clear labeling with antibiotic identification, precautions, contraindications, and storage requirements.
Our facility operates under Good Manufacturing Practice (GMP) protocols appropriate for pharmaceutical products. Environmental monitoring, equipment calibration, personnel training, and comprehensive batch documentation ensure complete quality traceability and regulatory compliance.
Temperature-controlled storage areas maintain products below 25°C as specified, with additional protection from direct sunlight that could degrade antibiotic potency or alter paraffin characteristics.
Laboratory Quality Control: Pharmaceutical Validation
Every batch of Polygrass Dressing undergoes rigorous examination by our Quality Control Department employing both pharmaceutical and medical device testing methodologies. Our protocols validate antibiotic potency, antimicrobial efficacy, and product safety.
Antibiotic potency assays employ microbiological methods to quantify Bacitracin Zinc and Polymyxin B Sulphate concentrations in the finished dressing. High-performance liquid chromatography (HPLC) or standardized bioassays confirm that antibiotic levels meet label claims within acceptable ranges. Only batches demonstrating specified potency proceed to release.
Antimicrobial efficacy testing validates the dressing’s ability to inhibit bacterial growth. Standardized challenge tests expose dressing samples to known concentrations of relevant bacterial species including Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. Zone of inhibition measurements or time-kill assays confirm effective antimicrobial action.
Sterility testing employs pharmacopoeial methods confirming complete absence of viable microorganisms. This testing is critical as any contamination could compromise patient safety and product effectiveness.
Paraffin impregnation uniformity testing ensures consistent distribution throughout the gauze structure. Samples from different dressing sections undergo paraffin content analysis to verify uniform impregnation that will provide consistent non-adherence and drug delivery characteristics.
Gauze substrate quality testing confirms the leno weave meets BP specifications including thread count, yarn fineness, weave uniformity, and dimensional accuracy. Physical testing verifies appropriate tensile strength and conformability.
Antibiotic stability testing monitors potency retention under accelerated aging conditions simulating extended storage. These studies confirm shelf life determinations and validate storage temperature requirements.
Packaging integrity testing ensures hermetic sealing that maintains sterility and protects against light and moisture that could degrade antibiotics. Package strength testing confirms the packaging protects product integrity throughout distribution.
Chemical purity testing verifies the paraffin and antibiotics contain no harmful contaminants or degradation products that could provoke adverse reactions.
No batch of Polygrass Dressing receives Cotton Craft certification without documented evidence that all pharmaceutical and device quality parameters meet specifications.
Verification & Market Validation: Trusted in Critical Applications
Following successful validation, Cotton Craft introduced Polygrass Dressing to burn units, surgical departments, wound care centers, and healthcare distributors throughout Pakistan and international markets. The response from specialists managing infection-vulnerable wounds has validated our pharmaceutical manufacturing capabilities and product design.
Burn care specialists consistently report satisfaction with infection prevention in thermal injury patients. The combination of broad-spectrum antimicrobial coverage and non-adherent paraffin impregnation supports the delicate balance required in burn wound management — controlling infection while promoting epithelial regeneration.
Plastic surgeons value the product’s performance on skin graft sites where even minor bacterial colonization can cause graft failure. The sustained antimicrobial release throughout the critical integration period supports improved graft survival rates.
Emergency departments appreciate having a readily available antimicrobial dressing for contaminated traumatic wounds requiring immediate infection prevention. The broad-spectrum coverage addresses the diverse bacterial populations encountered in environmental injuries.
Wound care clinics managing chronic leg ulcers report improved healing progression when bacterial burden is controlled with Polygrass Dressing. The combination therapy addresses the polymicrobial nature of chronic wound infections more effectively than single-agent products.
Healthcare distributors benefit from our comprehensive pharmaceutical documentation including stability data, microbiological validation, and manufacturing compliance records that support regulatory submissions and hospital formulary approvals.
Clinical feedback has reinforced the importance of appropriate patient selection. Healthcare providers report excellent outcomes when the dressing is used for bacterial-susceptible wounds with proper monitoring for hypersensitivity. Adherence to contraindications — avoiding use on fungal or viral lesions — ensures optimal clinical results.
Cotton Craft: Advancing Antimicrobial Wound Care
Polygrass Dressing represents Cotton Craft’s evolution into pharmaceutical-grade wound care products that integrate drug therapy with advanced dressing technology. The successful development and manufacturing of antibiotic-containing dressings demonstrates our commitment to expanding capabilities beyond conventional textiles into sophisticated medical devices.
Every Polygrass Dressing reflects our understanding that effective antimicrobial wound care requires pharmaceutical expertise, microbiological validation, and manufacturing precision that ensures consistent drug delivery. From antibiotic selection based on clinical evidence through formulation optimization and pharmaceutical quality control, each development step serves the goal of providing reliable infection prevention.
Whether protecting burn patients from life-threatening infections, supporting successful skin graft integration, managing contaminated traumatic wounds, or controlling bacterial colonization in chronic ulcers, healthcare professionals can trust that Cotton Craft Polygrass Dressing delivers verified antimicrobial efficacy, pharmaceutical-grade quality, and proven clinical performance.
For burn units, surgical departments, wound care centers, and distributors seeking antimicrobial dressing solutions backed by pharmaceutical manufacturing excellence, Cotton Craft offers specialized products, comprehensive technical support, and regulatory documentation that facilitates formulary approval and clinical adoption.
Cotton Craft continues to advance wound care technology — where every product is backed by research and real-world proof.
Important Safety Information
Precautions: Prolonged use may result in overgrowth of non-susceptible organisms, including fungi. Monitor patients for signs of secondary infection. If any signs or symptoms of hypersensitivity reaction develop (rash, itching, swelling), immediately discontinue use and consult a physician.
Contraindications: This product is contraindicated in individuals who have shown hypersensitivity to Bacitracin, Polymyxin B, or any components. Also contraindicated for fungal or viral lesions of the skin. Use only on bacterial-susceptible wounds as directed by healthcare professionals.
Storage: Store at temperatures not exceeding 25°C. Protect from direct sunlight which may degrade antibiotic potency. Keep in original packaging until use to maintain sterility and product stability.